• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

TTM2-trial soon to start

10 November 2017

After almost one year of planning we are delighted to announce that the TTM2-trial is soon ready to start in a selected group of vanguard sites. These sites will get the oportunity to give constructive feed back on instructions, trial infrastructure and protcol and will therefore pave the way for the main body of trial sites that will be initiated and start recruiting with the next quarter. Co-enrolment with the TAME-trial, additions of exiting and important sub-studies,  and the start up of a large biobank at the Integrated Biobank of Luxembourg will be inspiring projects within the TTM2-trial. Please take the oportunity to find additional trial material at this home page and look out for the news that the trial is launched.

News

TTM2 Trial Results Meeting

08 June 2021

Protocol for the TTM2 follow-up published in Resuscitaiton

15 April 2020

Covid-19 update

20 March 2020

Randomisation Complete!

20 January 2020

TTM2 - Trial design article (open access).

16 November 2019

Formal Interim analysis

04 October 2019

1000!

29 May 2019

Investigator meeting in Lund 22 May

22 May 2019

Largest cardiac arrest trial in an ICU setting

22 May 2019

New FAQs

04 February 2019

Pages

  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org